Pfizer Spends Big on IP Lobbying With Billions on the Line
The pharmaceutical giant spent big bucks amid key international negotiations last year to protect record earnings.
PhRMA
Page 2
STOCK TICKER: Blumenthal’s Wife Invests in Biotech Hedge Fund as He Chairs Panel Overseeing Drug Prices
As a consumer protection subcommittee chairman, Blumenthal has focused on the role pharmaceutical benefit managers play in driving up the cost of drugs.
Pharma Lobby Enlists Minority Groups to Fight Drug Pricing Reform
PhRMA-funded groups the National Hispanic Council on Aging and the National Minority Quality Forum say most voters of color do not support the Democrats' drug pricing reform proposal.
Senators Against Generic Covid-19 Vaccines Have Gotten 2x Pharma Cash
A group of Republican senators sought to block U.S. support for an IP waiver for Covid-19 vaccines, a proposal that is strongly opposed by the pharmaceutical industry.
Pharma Front Group Hosted House Staffers at Luxury Resort Before BBB Vote
Days before the House voted on the Build Back Better Act, Center Forward hosted dozens of congressional staffers to discuss policy issues with lobbyists.
News Outlet Founded by Blue Dog Dem Operatives Promotes Big Pharma's Lobbying Aims
Leaders of a centrist advocacy group with funding from the pharmaceutical industry founded outlet The Well News and have editorial input on its promoted posts.
Biden Plans to Enact Trump Rule Allowing Drug Companies to Price Gouge on Life-Saving Treatments
The plan, initiated by the Trump administration in January, would gut a key government power for making sure taxpayer-funded pharmaceuticals are available to the public at reasonable prices.
Koch Group Fights Drug Price Reforms After Taking Big Pharma Money
Americans for Prosperity is hitting six key moderate House Democrats with digital ads opposing reintroduced drug pricing measures.
Astroturf Campaign Attacks Discount Drug Program for the Poor
An anti-government waste group is helping its Big Pharma funder oppose a discount drug program that doesn’t cost the government a penny.
Corporate Lobbyist Bailout: DENIED
A startup watchdog group beat back legislation that would have allowed corporate trade groups that lobby the government to access PPP funding.